Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-05-000536
Filing Date
2005-07-07
Accepted
2005-07-07 13:57:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 avantimmuno.htm SC 13G 102569
2 AGREEMENT REGARDING JOINT FILING exhibit-99.htm EX-99 12914
  Complete submission text file 0000898432-05-000536.txt   117597
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 05943011
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice